(lp0
S'AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in ... PR Newswire  - Mar 17, 2017 REDWOOD CITY, Calif., March 17, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of&nbsp;...'
p1
aS'AcelRx Pharmaceuticals Presents Efficacy and Pharmacokinetics of DSUVIA at ... PR Newswire  - Mar 16, 2017 REDWOOD CITY, Calif., March 16, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p2
aS'AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in March PR Newswire  - Mar 1, 2017 REDWOOD CITY, Calif., March 1, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of&nbsp;...AcelRx Pharmaceuticals Inc  Set to Announce Earnings on Thursday - Sports Perspectives'
p3
aS'AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer PR Newswire  - Feb 16, 2017 REDWOOD CITY, Calif., Feb. 16, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...BRIEF-Acelrx Pharmaceuticals appoints Vincent Angotti as CEO - ReutersRecommended Mix Momentum Stocks: Facebook , AcelRx Pharmaceuticals ... - Street Wise Report '
p4
aS'AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results PR Newswire  - Mar 2, 2017 REDWOOD CITY, Calif., March 2, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain,&nbsp;...ACELRX PHARMACEUTICALS, INC.  Files An 8-K Other Events - Market ExclusiveAcelRx Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 03 - Equities.com'
p5
aS'AcelRx Pharmaceuticals: Blockbuster Potential Makes This $2 Stock A Strong Buy ... Seeking Alpha - Jan 10, 2017 AcelRx Pharmaceuticals shares appear deeply undervalued and could be poised for a short squeeze rally. This company has financial strength and two strong pipeline candidates, including a potential &quot;blockbuster&quot; that could get FDA approval in 2017.'
p6
aS"AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met its Primary Endpoint, Reduced ... PR Newswire  - Aug 15, 2016 REDWOOD CITY, Calif., Aug. 15, 2016 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;..."
p7
aS"Why AcelRx Pharmaceuticals Inc. Is Crashing Motley Fool - Mar 10, 2015 What's happening: Shares in AcelRx Pharmaceuticals  continued their decline today, falling by as much as 10% after the company reported disappointing fourth quarter results. The drop follows yesterday's 37% collapse on news that the FDA&nbsp;...AcelRx Pharmaceuticals  Stock Extends Losses Today as Jefferies Downgrades - TheStreet.com"
p8
aS'AcelRx Initiates Phase 3 Study of Zalviso in Patients with Moderate-to-Severe ... PR Newswire  - Sep 27, 2016 REDWOOD CITY, Calif., Sept. 27, 2016 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...Stock Update : AcelRx Pharmaceuticals Inc Initiates Phase 3 Study ... - Smarter AnalystAcelRx launches late-stage study of pain med device Zalviso in hospital setting - Seeking Alpha'
p9
aS'AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy PR Newswire  - Oct 1, 2015 REDWOOD CITY, Calif., Oct. 1, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today&nbsp;...'
p10
a.